Literature DB >> 25553957

MiRNA inhibition in tissue engineering and regenerative medicine.

Kelsey R Beavers1, Christopher E Nelson2, Craig L Duvall3.   

Abstract

MicroRNAs (miRNAs) are noncoding RNAs that provide an endogenous negative feedback mechanism for translation of messenger RNA (mRNA) into protein. Single miRNAs can regulate hundreds of mRNAs, enabling miRNAs to orchestrate robust biological responses by simultaneously impacting multiple gene networks. MiRNAs can act as master regulators of normal and pathological tissue development, homeostasis, and repair, which has motivated expanding efforts toward the development of technologies for therapeutically modulating miRNA activity for regenerative medicine and tissue engineering applications. This review highlights the tools currently available for miRNA inhibition and their recent therapeutic applications for improving tissue repair.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-miR; MiRNA; MiRNA inhibition; Regenerative medicine; Tissue engineering

Mesh：

Substances：

Year:  2014        PMID： 25553957      PMCID： PMC4485980          DOI： 10.1016/j.addr.2014.12.006

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


  195 in total

Review 1.  Developing microRNA therapeutics.

Authors:  Eva van Rooij; Angela L Purcell; Arthur A Levin
Journal:  Circ Res       Date:  2012-02-03       Impact factor: 17.367

2.  The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a.

Authors:  Yan Li; Longkun Fan; Shiyu Liu; Wenjia Liu; Hao Zhang; Tao Zhou; Dan Wu; Ping Yang; Lijuan Shen; Jihua Chen; Yan Jin
Journal:  Biomaterials       Date:  2013-04-08       Impact factor: 12.479

3.  Sponge transgenic mouse model reveals important roles for the microRNA-183 (miR-183)/96/182 cluster in postmitotic photoreceptors of the retina.

Authors:  Qubo Zhu; Wenyu Sun; Kiichiro Okano; Yu Chen; Ning Zhang; Tadao Maeda; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

Review 4.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

5.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

Review 6.  Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure.

Authors:  Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 7.  MicroRNAs and their role in progressive kidney diseases.

Authors:  Mitsuo Kato; Laura Arce; Rama Natarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-07       Impact factor: 8.237

8.  Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier.

Authors:  Kim A Lennox; Richard Owczarzy; Derek M Thomas; Joseph A Walder; Mark A Behlke
Journal:  Mol Ther Nucleic Acids       Date:  2013-08-27       Impact factor: 10.183

9.  Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin.

Authors:  Haoran Li; Leslie Chang; William W Du; Shaan Gupta; Azam Khorshidi; Michael Sefton; Burton B Yang
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

10.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.

Authors:  Michaela Scherr; Letizia Venturini; Karin Battmer; Michael Schaller-Schoenitz; Daniel Schaefer; Iris Dallmann; Arnold Ganser; Matthias Eder
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971
View more
  22 in total

Review 1.  Technologies for controlled, local delivery of siRNA.

Authors:  Samantha M Sarett; Christopher E Nelson; Craig L Duvall
Journal:  J Control Release       Date:  2015-11-28       Impact factor: 9.776

Review 2.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

Review 3.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  MicroRNAs in injury and repair.

Authors:  Cory V Gerlach; Vishal S Vaidya
Journal:  Arch Toxicol       Date:  2017-05-13       Impact factor: 5.153

5.  Light-triggered RNA release and induction of hMSC osteogenesis via photodegradable, dual-crosslinked hydrogels.

Authors:  Cong Truc Huynh; Minh Khanh Nguyen; Mantas Naris; Gulen Yesilbag Tonga; Vincent M Rotello; Eben Alsberg
Journal:  Nanomedicine (Lond)       Date:  2016-06-01       Impact factor: 5.307

Review 6.  BMP gene delivery for skeletal tissue regeneration.

Authors:  Maxim Bez; Gadi Pelled; Dan Gazit
Journal:  Bone       Date:  2020-05-21       Impact factor: 4.398

Review 7.  MicroRNAs as therapeutic targets in breast cancer metastasis.

Authors:  Fahima Danesh Pouya; Yousef Rasmi; Maria Gazouli; Eleni Zografos; Mohadeseh Nemati
Journal:  Drug Deliv Transl Res       Date:  2021-05-13       Impact factor: 4.617

8.  Hydrogel microspheres for spatiotemporally controlled delivery of RNA and silencing gene expression within scaffold-free tissue engineered constructs.

Authors:  Alexandra McMillan; Minh Khanh Nguyen; Cong Truc Huynh; Samantha M Sarett; Peilin Ge; Melanie Chetverikova; Kien Nguyen; David Grosh; Craig L Duvall; Eben Alsberg
Journal:  Acta Biomater       Date:  2021-01-16       Impact factor: 8.947

Review 9.  Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering.

Authors:  Yu Seon Kim; Antonios G Mikos
Journal:  J Control Release       Date:  2020-12-31       Impact factor: 9.776

10.  MicroRNA Profiles of Maternal and Neonatal Endothelial Progenitor Cells in Preeclampsia.

Authors:  Lars Brodowski; Bianca Schröder-Heurich; Sandra von Hardenberg; Katja Richter; Constantin S von Kaisenberg; Oliver Dittrich-Breiholz; Nadia Meyer; Thilo Dörk; Frauke von Versen-Höynck
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.